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Abstract
Background: The vestibular system is connected to spinal, cerebellar and cerebral motor control structures and can be
selectively activated with external electrodes. The resulting sensation of disturbed balance can be avoided by using
stochastic stimulation patterns. Adding noise to the nervous system sometimes improves function. Small clinical trials
suggest that stochastic vestibular stimulation (SVS) may improve symptoms in Parkinson’s disease. We have investigated
this claim and possible mechanisms using the 6-hydroxydopamine (6-OHDA) hemilesion model of Parkinson’s disease.
Methodology/Principal Findings: Animals were tested in the accelerating rod test and the Montoya staircase test of skilled
forelimb use. In 6-OHDA hemilesioned animals, SVS improved rod performance by 56611 s. At group level L-DOPA
treatment had no effect, but positive responders improved time on rod by 60619 s. Skilled forelimb use was not altered by
SVS. To investigate how SVS may influence basal ganglia network activity, intracerebral microdialysis was employed in four
regions of interest during and after SVS. In presence of the c-amino buturic acid (GABA) transporter inhibitor NNC 711, SVS
induced an increase in GABA to 150615% of baseline in the substantia nigra (SN) of unlesioned animals, but had no effect
in the pedunculopontine nucleus (PPN), the striatum or the ventromedial thalamus (VM). Dopamine release remained stable
in all areas, as did GABA and amine concentrations in the SN of unstimulated controls. Following SVS, a sustained increase in
GABA concentrations was observed in the ipsilesional, but not in the contralesional SN of 6-OHDA hemilesioned rats. In
contrast, L-DOPA treatment produced a similar increase of GABA in the ipsi- and contra-lesional SN.
Conclusions/Significance: SVS improves rod performance in a rat model of Parkinson’s disease, possibly by increasing nigral
GABA release in a dopamine independent way. We propose that SVS could be useful for treating symptoms of Parkinson’s
disease.
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Introduction
Standard Parkinson’s disease treatments with dopaminergic
drugs, and sometimes deep brain stimulation, often fail to alleviate
axial rigidity and gait problems. Axial symptoms are strongly
related to the risk of falls and better treatment options could be of
great benefit to a large group of patients with Parkinson’s disease
[1].
Recent findings suggest that a sufficient level of noise may be
necessary for normal function of the central nervous system
[2,3,4,5,6]. Under some circumstances, adding noise to a system
will result in improved signal detection or linearity of responses
[7,8,9,10]. This phenomenon can be predicted from mathematical
models and is often referred to as stochastic resonance, or in a
wider sense, noise benefit [11]. Several recent studies describe
cross-modal noise benefit in cognitive tasks in healthy subjects
[12,13,14,15,16], indicating that noise benefit is not restricted to
signal detection but can be observed also when the outcome is a
complex and abstract behavior. In a computational model of the
degenerating brain, higher levels of external noise were needed for
optimal function under conditions representing aging and loss of
plasticity [4]. This could imply that the effects of neurodegener-
ation can be counteracted to some extent by introducing more
noise in the central nervous system.
Noisy sensory signals can be transmitted to the central nervous
system through any sensory pathway, but vestibular pathways
have some characteristics that may be particularly useful for
modulating motor deficits. Neurons in the vestibular brainstem
nuclei influence axial motor functions, eye movements, autonomic
cardiovascular reflexes, as well as spatial perception. Several
cortical regions respond to vestibular stimulation [17] indicating
widespread indirect effects. Galvanic stimulation of the vestibular
system using DC current has been used for over a hundred years
and is safe, but leads to disturbed posture and balance. However,
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by using stochastic current patterns, it is possible to activate the
vestibular system without such adverse effects [18,19,20,21]. Such
stochastic vestibular stimulation (SVS) can improve balance in
healthy subjects [22,23]. In patients with neurodegenerative
disease, like Parkinson’s disease, there is some evidence that SVS
improves motor functions [19,24], autonomic reflexes and
cognitive executive control [19]. Static postural sway is also
reduced by SVS in Parkinson disease patients [25]. It is not known
if there is a general mechanism for noise benefit in higher
functions. A model involving altered dopamine release has been
proposed [26], but experimental evidence to support that is
lacking [27].
We used the 6-OHDA hemilesioned rat model to determine if
SVS can improve motor functions in dopamine-deficient rats.
Furthermore, we investigated how SVS might influence basal
ganglia networks under normal and dopamine deficient conditions
by measuring amino acid and dopamine release in intact and 6-
OHDA hemilesioned rats.
Four nuclei that relay or mediate basal ganglia signaling were
investigated in intact rats: the SN, the striatum, the PPN and the
VM. Dopamine release in the striatum and SN is known to
facilitate movement initiation and to occur during motor activity
[28,29,30]. The output from the basal ganglia is inhibitory and
mainly mediated by GABA-ergic neurons projecting from the
internal globus pallidus (entopeduncular nucleus in rodents) and
the SN pars reticulata to thalamus and brainstem nuclei including
the PPN. The PPN is of particular interest as it responds to a large
number of sensory stimuli and is involved in gait initiation [31].
Furthermore cholinergic/glutamatergic PPN neurons project to
the SN and influence motor functions [32].
In line with previous clinical studies, we report improved
locomotion in hemilesioned rats during SVS, but we were unable
to demonstrate a change in skilled forepaw use. In unlesioned rats,
SVS increased extracellular GABA concentrations only in the SN.
The other investigated neurotransmitters were not significantly
altered in the SN, striatum, PPN and VM. In hemilesioned
animals, L-DOPA injections induced similar GABA increases in
the ipsi- and contralesional SN, whereas SVS induced differential
effects in the two SN, suggesting that altered nigral GABA release
has a role for the behavioral effects of SVS in 6-OHDA
hemilesioned rats, possibly by decreasing the inhibitory activity
of the ipsilesional SN pars reticulata neurons.
Results
Effects of SVS and L-DOPA on rotarod performance in 6-
OHDA and sham hemilesioned rats
Unilateral 6-OHDA lesion resulted in reduced performance on
the rotarod. The total time on the rod decreased by 48% from
472680 s before the lesion to 266686 s after (2206645 s, paired
t-test, p,0.01). In contrast, the sham procedure did not
significantly reduce the total time on the rod (pre-sham
performance: 5446135 s, post-sham performance: 4306112 s,
paired t-test p = 0.1004).
Because individual animals differ slightly in performance from
day to day the effect of treatments were evaluated in comparison
to a baseline performance obtained immediately before interven-
tion. Treatment or sham treatment was administered in a
balanced pseudo-randomized order so each animal received either
sham treatment or active treatment first, and the remaining
intervention in a separate trial. Baseline performances immedi-
ately before SVS and sham SVS did not differ (272675 s and
279677 s, respectively, paired t-test, p = 0.526), and this was the
case also with baseline performances immediately before L-DOPA
and NaCl administration (265662 s and 244657 s, respectively,
paired t-test, p = 0.511).
6-OHDA hemilesioned animals increased the time spent on rod
during SVS compared to baseline significantly more than during
sham SVS (Dt = 56611 s vs. Dt = 24611 s, paired t-test,
p = 0.011, Fig. 1). The improvement observed during SVS
corresponded to an increase in performance of 2466% of the
immediately preceding baseline performance. As changes in
neurotransmission were sustained (see below), we also analyzed if
the order of treatment had an effect. Analysis of variance with
treatment and test day order as independent factors revealed no
effect of test day order, F(1,8) = 0.0003, p = 0.987, failing to show a
carry-over effect of SVS to the following test session. At group
level, L-DOPA treatment did not improve the mean time spent on
the rod relative to baseline and was in that respect not better than
sham treatment with a saline injection (paired t-test, p = 0.818,
Fig. 1). At the individual level, however, animals could be
categorized as positive responders to L-DOPA (n = 3) or negative
responders (n = 3). The positive responders increased time on rod
by 60619 s compared to the preceding baseline and this was
nearly significant (p = 0.067, paired t-test) compared to saline
injection (2567 s). In contrast, in negative responders, time on
rod changed by 263615 s compared to the preceding baseline in
response to L-DOPA and by 11630 s in response to vehicle (not
significant).
Sham-lesioned animals (n = 5) did not perform better during
SVS than no SVS (paired t-test for change from preceding
baseline, p = 0.8206, n = 5. Fig. 1). Similar to L-DOPA treated
hemilesioned animals the response to SVS was variable in this
group. One animal improved by 192 s, and another deteriorated
by 138 s during SVS. The other three retained stable perfor-
mance.
Effects of SVS on skilled forelimb use
Forelimb use was evaluated with the Montoya staircase test. As
expected there was a significant decrease in the ratio of pellets
picked up with the contralesional forelimb following a 6-OHDA
Figure 1. Rotarod performance after 6-OHDA or sham-hemile-
sions. Dt represents the change in time on rod (s, mean6SEM)
compared to baseline performance on the day of the experiment.
Stochastic vestibular stimulation (SVS) or no stimulation (No SVS) was
administered in a counterbalanced order. In the following week a
repeat experiment was performed with 6-OHDA hemilesioned animals
and the effect of L-DOPA treatment or a vehicle injection (NaCl) was
evaluated in counterbalanced order. P-value for paired t-test.
doi:10.1371/journal.pone.0029308.g001
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hemilesion (0.9360.1 prelesion vs. 0.6560.1 postlesion, paired t-
test, p = 0.035). No statistical difference was found between the
total number of pellets retrieved before and after the 6-OHDA
lesion. Unlike 6-OHDA hemilesioned animals, the sham-lesioned
animals retrieved a higher number of pellets after the lesion
procedure than before, suggesting continued performance im-
provement, and they did not develop a side preference (Table 1).
For technical reasons we were unable to administer SVS during
the skilled forelimb task, and we did not observe any change in the
total number of retrieved pellets or the ratio retrieved with the
contralesional forelimb when animals were tested immediately
after a 30 minutes SVS-session (Table 1).
Effects of SVS on dopamine and amino acids in un-
lesioned animals
We used un-lesioned animals to broadly investigate if SVS
induces any detectable changes in neurotransmitter release in four
key brain regions in, or connected to, the basal ganglia (Fig. 2).
Extracellular concentrations of dopamine, dopamine metabolites
and amino acids were sampled from microdialysis probes in the
SN, the striatum, the PPN and the VM before, during and after
SVS. The GABA transporter inhibitor NNC 711 was retro-
dialysed to amplify synaptic release of GABA as we have
previously demonstrated that rapid increases in GABA transmis-
sion can otherwise go undetected [33].
Following SVS in un-lesioned animals, dialysate GABA
concentrations from the SN increased to 150615% of baseline
(at T = 150 min), while GABA concentrations in control animals
that received no SVS were stable (Fig. 3A, Two way ANOVA,
main effect of treatment F(1,26) = 14.41, p = 0.0022, time
F(2,26) = 3.83, p = 0.035 and interaction treatment6time
F(2,26) = 3.53, p = 0.044). The deadspace of tubings introduced
a delay of approximately 20–30 minutes in the microdialysis
measurements. This means that the observed increase in GABA
started early during SVS-stimulation and persisted for at least
30 minutes after stimulation was terminated. DA concentrations
remained stable in the SN and striatum of SVS-treated animals
during SVS and the following 60 min (Fig. S1).
DA concentrations were below detection levels (0.05 nM) in the
PPN and VM throughout the experiment. No significant changes
in GABA concentrations were measured in the PPN, VM, or the
striatum following SVS in un-lesioned animals (Fig. 3B). Concen-
trations of glutamate, aspartate, glycine, taurine, serine, alanine,
DOPAC and HVA were not significantly affected by SVS in any
of the investigated regions (not shown), but in the SN, there were
large variations in glycine and glutamate concentrations after SVS
(Fig. S2).
Effects of SVS and L-DOPA treatment on dopamine and
GABA in 6-OHDA hemilesioned animals
Based on our findings in unlesioned animals, dopamine and
amino acid concentrations were measured in the bilateral SN of
some hemilesioned 6-OHDA animals, during and after SVS and
L-DOPA treatments. These animals were not tested behaviorally,
but the degree of dopamine lesion was assessed after the
experiment. The effects of treatments on the nigral concentrations
of DA, GABA and glutamate were evaluated and compared
between the ipsilesional and contralesional SN.
In the 6-OHDA hemilesioned animals there was a trend
towards lower baseline GABA concentrations in the ipsilesional
SN at the beginning of sampling, but the difference was not
significant (ipsin = 6: 2466 nM vs. contran = 6: 50620 nM,
p = 0.353, paired t-test. In unlesioned animals, n = 15, absolute
baseline concentrations were 50617 nM).
Following SVS, the absolute GABA concentration changed
differently in the two SN. In the ipsilesional SN GABA
concentrations increased and in the contralesional SN they tended
to fall. This differential effect is expressed as a significant
interaction between time and SN side in a two way ANOVA
using the absolute GABA concentrations at t = 90 to t = 150 min-
utes as the independent variable (Fig. 4A, F(2,20) = 4.89,
p = 0.019).
In contrast, L-DOPA treatment on day two produced roughly
parallel changes in absolute GABA concentrations in the two SN,
despite apparent asymmetries in the dopamine concentrations in
the two SN following the L-DOPA injection (Fig. 4B). The relative
changes in GABA concentrations in the bilateral SN following L-
DOPA treatment (Fig. 5) was of similar magnitude to that
observed after SVS in intact animals (Figs. 3, 5) and in the
ipsilesional SN, GABA concentrations (percent of baseline) were
significantly increased compared to untreated control animals at
T = 120 (Fig. 5). Due to tubing deadspace, that timepoint
corresponds to approximately 30–40 minutes after L-DOPA
administration.
Like in unlesioned animals SVS did not alter DA concentrations
in the bilateral SN of 6- OHDA hemilesioned animals (Fig. 4C).
After the L-DOPA administration the DA concentrations
increased in both ipsi- and contralesional SN and peaked in the
first succeeding sample (T = 90, Fig. 4D). This indicates that DA
levels peaked within 10 minutes after the L-DOPA injection. The
increase in DA following L-DOPA treatment was in absolute
terms more than two times larger in the ipsilesional SN (ipsin = 4:
+2.060.3 nM, contran = 5: +0.960.2 nM, p = 0.028, unpaired t-
test), but peak values were not significantly higher in the
ipsilesional SN (ipsin = 4: 2.360.4 nM, contran = 5: 1.560.2 nM,
p = 0.119). For technical reasons however, only two measurements
could be obtained from the ipsilesional SN at T = 90, so peak
values from the ipsilesional SN may be underestimated.
Concentrations of the amino acid glutamate in dialysates from
the two SN of 6-OHDA hemilesioned animals were also analyzed.
Following SVS, as well as L-DOPA injection, no significant
changes or differences between the two sides were observed (Fig.
S3.).
Discussion
This is to our knowledge the first study to evaluate motor effects
of stochastic vestibular stimulation (SVS) in rodents, and the first
to explore the neurochemical effects of SVS in vivo. Stochastic
resonance in central nervous system function has previously
mainly been studied as a phenomenon, without trying to
understand how activity patterns in the brain may change. This
Table 1. Montoya staircase performance before and two
weeks after a hemilesion procedure.
Pre
lesion Post les p-value No SVS SVS p-value
6-OHDA Total 5162 4563 0.377 4563 4663 0.753
(n = 5) Ratio 0.9360.1 0.6560.1 0.035 0.5860.1 0.5460.1 0.618
Sham Total 4063 5063 0.005 5064 4663 0.497
(n = 3) Ratio 1.2360.2 1.0560.1 0.239 1.2560.3 1.1060.2 0.520
Total number of pellets retrieved and the contralesional/ipsilesional ratio is
given (mean6SEM) Three weeks post lesion, the effect of stochastic vestibular
stimulation (SVS) or no stimulation (No SVS) was evaluated on different days in
a counterbalanced order. P-values for paired t-tests.
doi:10.1371/journal.pone.0029308.t001
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study demonstrates that SVS improves rod performance in
hemilesioned rats. SVS was associated with increased GABA
concentrations in the SN, but not with altered dopamine
transmission in normal animals. In hemilesioned rats SVS
increased GABA in the ipsilesional SN by a magnitude similar
to that observed after L-DOPA treatment. As described previously
[34], L-DOPA treatment increased nigral DA release. In contrast,
SVS was not associated with altered dopamine release in lesioned
animals.
For technical reasons we used two different stimulation setups
and stimulation currents were not identical (Fig. S4). The current
used in behavioral experiments and microdialysis experiments in
hemilesioned animals contained more frequencies over 30 Hz
than the current used in microdialysis in unlesioned animals.
Although vestibular neurons can support activity frequencies well
over 100 Hz, the vestibular system is optimized for frequencies up
to ,30 Hz [35]. The low frequency content of the signal can
therefore be expected to have a higher impact on brainstem
activity. The neurochemical effects of the two currents were
however similar, and importantly both protocols stimulated
vestibular afferents in a way that did not cause observable
nystagmus or balance deficits.
Behavioral effects of SVS
Stochastic resonance (SR) is characterized by a biphasic
response curve shaped as an inverted U [5]. The design of this
study did not include more than one noise level per animal, so we
cannot know if the observed improvement in rod performance
involves SR. A SR phenomenon has been demonstrated
previously for balance improvement with SVS [22], and adding
noise with small amplitude, both electrical and mechanical, to
proprioceptive pathways improves balance [36,37]. The observa-
tion that 6-OHDA hemilesioned, but not sham lesioned animals,
improved rod performance can be interpreted as support for the
notion that brains with impaired function display more noise
benefit than the normally working brain [4,26,27]. The lack of
improvement in sham lesioned animals is not likely to be only a
ceiling effect, as the group response included both large
improvement and impairment in response to SVS. Although SR
can serve as a theoretical framework for understanding the effect
of noisy sensory stimulation like SVS, it remains an unproved
hypothesis that the effects of external noise on central nervous
system functions involve SR. SVS could alternatively be viewed as
a method to specifically activate the vestibular system without the
adverse effects associated with stimulation with regular pattern.
SVS improved rod performance which is an integral measure of
balance and locomotion. Improvements in time on an accelerating
rod indicate not only improved endurance but also an increase in
motor and balance functions, because the difficulty of the task
increases gradually. The effect of SVS on rod performance was of
similar magnitude as the effect of a single L-DOPA injection in
positive responders, suggesting that the efficacy of SVS in terms of
improved rod performance is not marginal. Furthermore, unlike
L-DOPA treatment, SVS improved the rod performance in all
lesioned animals.
The vestibular pathways are mainly influencing axial motor
systems and a stronger effect of SVS on balance and locomotion
than on appendicular motor control can therefore be expected. As
there are reports of cross modal function improvements following
noisy sensory stimulation [16,38], we hypothesized that skilled
forelimb use would also improve in response to SVS. We were,
Figure 2. Vestibular pathways that may influence basal ganglia transmission. A) SVS is expected to activate multiple pathways from the
vestibular nuclear complex (VN). Of particular interest may be pathways that connect the cerebellum and the basal ganglia over the subthalamic
nucleus and thalamus [48,49]. We chose to sample the SN, the striatum, the PPN and the VM for dopamine and amino acid concentrations before,
during and for 60 minutes after stochastic vestibular stimulation in unlesioned animals. Panel B indicates the activity of the direct and indirect loop
projections to the SN in normal intact rats and after nigral dopamine cell degeneration. Loss of nigrostriatal dopamine neurons lead to
hyperexcitation of SN pars reticulata neurons, which can be counteracted by increased GABA release following L-DOPA treatment. SVS also increases
nigral GABA concentrations, but the pathways involved in this effect remains to be elucidated. RF: reticular formation, SNc: Substantia nigra pars
compacta, SNr: Substantia nigra pars reticulata, STN: subthalamic nucleus, SVS: stochastic vestibular stimulation, Thal: thalamus.
doi:10.1371/journal.pone.0029308.g002
Vestibular Noise and Basal Ganglia Function
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29308
however, unable to demonstrate any effect of SVS in the Montoya
stair case test. It therefore appears that noise benefit did not spread
to forepaw motor function. Because SVS could not be adminis-
tered in the Montoya box, an alternative explanation is that the
effect of SVS wanes off rapidly. However, microdialysis measure-
ments show that the increase in nigral GABA release is sustained
for at least 30 minutes after SVS, making that explanation for the
lack of observed effects on skilled forelimb use less likely. Future
studies should also evaluate neurotransmission in the entopedun-
cular nucleus, the rodent equivalent of globus pallidus pars interna,
an output structure which is analogue to SN pars reticulata and in
more direct control of appendicular motor programs in humans
[39].
A positive effect of SVS on axial muscle functions may have
some clinical implications because axial rigidity and imbalance in
Parkinson’s disease are often difficult to control with L-DOPA and
subthalamic DBS [40,41].
The effects of SVS on neurotransmission
The detection of rapid increases in GABA release with
microdialysis sampling is improved by using a GABA re-uptake
inhibitor (NNC 711) in the perfusion fluid [33]. One concern with
this approach is that the re-uptake inhibitor may prolong and
extend the increase in GABA concentrations and that this could
lead to secondary changes in network activity. The increase in
nigral GABA release following SVS is, however, not a long term
effect of NNC 711 retrodialysis, because GABA concentrations
remained stable in retrodialysed animals that did not receive SVS
but were only retrodialysed with NNC 711 (Fig. 3A). Furthermore,
Figure 3. Microdialysate concentrations of GABA during
stochastic vestibular stimulation (SVS) in intact animals and
untreated intact controls. Percent of baseline, mean6SEM is shown.
The GAT-inhibitor NNC 711 was included in the dialysates throughout
the experiment. The SVS period is indicated by a horizontal bar. A.
Nigral GABA concentration in SVS treated intact animals (n = 9) and
untreated controls (n = 6). P-values from Bonferroni corrected post hoc
tests following two-way ANOVA for timepoints T = 90–T= 150 minutes,
indicating significant interaction between treatment and time
F(2,26) = 3.53, p = 0.044. B. GABA concentrations in the PPN, VM and
striatum of intact animals following SVS.
doi:10.1371/journal.pone.0029308.g003
Figure 4. Absolute concentrations of GABA and dopamine in
the ipsi- and contralesionalSN of hemilesioned 6-OHDA
animals. Panel A–B shows the GABA concentrations and panel C–D
the simultaneous dopamine (DA) concentrations following stochastic
vestibular stimulation (SVS) and L-DOPA treatment (nM, mean6SEM).
Panel A and C are measurements from day 1 and B and D from day 2.
NNC 711 (30 mM) was present throughout the experiment and left in
the microdialysis tube that was re-sealed over night. SVS treatment is
indicated by a horizontal bar and the L-DOPA injection by an arrow.
doi:10.1371/journal.pone.0029308.g004
Vestibular Noise and Basal Ganglia Function
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the increase occurred selectively in the SN and not in the other
investigated nuclei following the vestibular stimulation.
The microdialysis measurements did not reveal any other
significant changes in neurotransmitter concentrations following
SVS than the increase in nigral GABA. Because microdialysis
measurements of amino acids do not necessarily reflect synaptic
release activity [42], at least not without using a reuptake inhibitor
or stimulated release, this does not exclude altered activity and
release of neurotransmitters other than dopamine and GABA in
the investigated regions. In microdialysates from the SN, mean
values of glutamate and glycine increased following SVS, but the
change was not significant. It may be possible to determine if this
represents an increase in afferent activity by measuring stimulated
release or reuptake inhibitors. Immediate early gene expression
may also be informative regarding by which mechanism nigral
GABA release increases following SVS.
Nigrostriatal dopamine lesions lead to increased activity of the
indirect loop and decreased activity of direct loop [43,44], and a
decrease in GABA release in the SN can therefore be expected
(Fig. 2). Increasing GABA release in the SN disinhibits the
activation of motor programs and counteracts Parkinsonism. This
is illustrated by the increase in nigral GABA concentrations that
was observed following L-DOPA treatment, a treatment that is
known to ameliorate Parkinsonism. There are obvious similarities
between the nigral GABA increases observed after SVS in intact
animals and the nigral increases in GABA after L-DOPA
treatment of hemilesioned rats, not least regarding the timing of
the GABA increase. Because SVS was not associated with altered
dopamine release in striatum (or SN) it appears that the SVS-
induced increase in nigral GABA release is not mediated by the
action of dopamine on striatonigral GABA neurons. It is beyond
the scope of this article to determine which pathways may mediate
the observed nigral GABA increase following SVS, but as
indicated in Fig. 2, vestibular neurons project to the cerebellum
and the formatio reticularis, and possibly the PPN; all structures that
may directly or indirectly alter neurotransmission in the SN. The
subthalamic nucleus was not investigated in this study but may be
of particular interest as DBS of the subthalamic nucleus has well
documented antiparkinsonian effects, and increases nigral GABA
and glutamate release [45].
Surprisingly, SVS did not induce similar changes in GABA
release in the ipsi- and contralesional SN. Despite the bilateral
nature of SVS the changes in GABA release in the two SN were in
opposite direction, towards a more balanced GABA release
between the two SN. Although we have no explanation for this
phenomenon, it may have some relevance for the consistent
improvement in rod performance that was observed after SVS, but
not after L-DOPA treatment. Because L-DOPA increases nigral
GABA release bilaterally, it may not reduce the imbalance in
locomotor functions that is detrimental for rod performance. This
could perhaps also explain why the initial laterality of Parkinson-
ism remains clearly observable throughout the course of the
disease also in optimally treated Parkinson’s disease patients.
Conclusion
SVS improves rod performance in 6-OHDA hemilesioned rats.
We observed a prominent and sustained increase in GABA release
in the SN following SVS, but no change in dopamine release in
the SN or striatum. We propose that vestibular stimulation leads to
a dopamine independent disinhibition of basal ganglia output that
could promote movement initiation. We suggest that it should be
evaluated as a treatment alternative for Parkinson’s disease, in
particular with prominent axial involvement.
Materials and Methods
Animals
Experimental design and procedures on unlesioned animals
were carried out in compliance with the UK Animal (Scientific
Procedures) Act 1986 (unlesioned animals) and approved by the
UK Home Office under project license no 60/3334. Experimental
design and procedures for experiments involving hemilesioned and
sham lesioned animals were carried out in compliance with the
European Communities Council Directive of November 24th,
1986 and approved by Go¨teborgs djurfo¨rso¨ksetiska na¨mnd, the local
ethics committee in Gothenburg, Sweden, under project license
no. 331/10. Experiments on unlesioned animals were performed
using 18 male Lister-Hooded rats (120–150 g, age 5–6 weeks,
Charles River Ltd, UK), 10 of these received microdialysis probes
in striatum/SN and 8 received probes in PPN/VM. Experiments
with 6-OHDA and sham-lesioned animals were performed using
32 female Sprague-Dawley rats (150–200 g, age 6–8 weeks,
Charles River, Germany). For the microdialysis tests 12 of these
were lesioned and 4 were sham lesioned. The other 16 animals
were used for behavioral tests subsequent to a hemilesion in 11 of
them and a sham-hemilesion in 5 of them. Animals were housed
4–6 per cage under standard controlled environmental conditions.
After implantation of microdialysis guides they were single-caged
for the remainder of the experiment.
Surgical procedures
All procedures were performed in deep surgical anesthesia (1.7–
2.5% isoflurane). The surgical area was shaved and disinfected
before lidocaine (1%) was infused subcutaneously for pre-emptive
analgesia. Ketoprofen (5 mg/kg, s.c.) was administered as needed
for post surgical analgesia.
Figure 5. Relative changes in GABA concentrations in the ipsi-
and contralesional substantia nigra of hemilesioned 6-OHDA
animals following L-DOPA treatment. The microdialysate concen-
trations of GABA (percent of baseline, mean6SEM, n = 5–7) in the
bilateral substantiae nigrae (SN) of 6-OHDA hemilesioned rats following
an i.p. injection of L-DOPA are compared to GABA concentrations in the
SN of untreated control animals (n = 6). Two-way repeated measure
ANOVA for t = 90–t = 150 with L-DOPA treatment and time as main
factors indicated a significant effect of treatment F(2,30) = 4.68,
p = 0.026. * p,0.05 in post hoc Bonferroni corrected t-tests comparing
ipsilesional SN in treated animals to control SN.
doi:10.1371/journal.pone.0029308.g005
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6-hydroxydopamine hemilesion
The animal was placed in a stereotactic frame with bregma and
lambda in the horizontal plane. After exposure of the skull, a hole
was drilled over the medial forebrain bundle (4.2 mm posterior
and +/2 1.2 mm lateral to bregma). A 150 mm diameter fused
silica capillary was lowered 8 mm below the dura mater and 10 mg
of 6-OHDA (Sigma Aldrich) dissolved in 0.9% NaCl, 0.3%
ascorbate, 5 mg/ml, was injected over 2 minutes. The capillary was
slowly removed after another minute and the brain surface was
covered with periost membrane before closing the wound. Sham-
treated animals received the saline ascorbate vehicle only.
Implantation of vestibular electrodes
Bilateral vestibular stimulation electrodes were attached by
securing the 1 mm peeled end of a teflon coated stainless steel wire
(0.2 mm diameter) over the horizontal canals of the two labyrinths
by pushing short wire loops through the most ventral ends of the
bilateral petrosal crests. The electrode wires were fixed to an
acrylic cement foundation on the skull and externalized. Animals
receiving microdialysis implants were implanted with electrodes in
the same surgical session.
Microdialysis probe implantation
The unlesioned animals were stereotactically implanted with
guide cannulae two days before microdialysis experiments. The
skull was exposed and holes were drilled over two of the target
nuclei. Targets were identified in the Paxinos and Watson rat
brain atlas [46] and the coordinates relative to bregma were for
the striatum: +1.0 mm anterior, 2.8 mm lateral, for the SN:
5.3 mm posterior, 2.1 mm contralateral, for the PPN: 8.0
posterior, 1.8 mm lateral, and for the VM: 2.6 posterior,
1.5 mm contralateral). Holes were also drilled in the parietal
bones to fasten two stainless steel jewellers’ screws. The dura was
opened and the underlying pial membrane was opened by pulling
it gently with fine forceps. Microdialysis guides (MAB 4.15.IC,
Microbiotech, Sweden) were slowly implanted to a depth
immediately above the target nucleus (6.0 mm from the brain
surface for the PPN and VM, 3.2 mm and 6.2 mm for the
striatum and the SN, respectively). The guide cannulae were
secured to the skull with acrylic dental cement.
Some 6-OHDA hemilesioned animals were chronically im-
planted with in-house constructed microdialysis probes positioned
bilaterally in the SN as described previously [47] and provided
with vestibular electrodes as described above. Animals were
allowed to recover for 24–48 h before the first microdialysis
experiment.
Microdialysis
Two days after implanting the microdialysis guide cannulae, the
unlesioned animals were briefly anaesthetized to insert bilateral
microdialysis probes (Cuprophane membranes extending 1 mm,
or with striatum guides, 3 mm, below the guide, MAB 4.15,
Microbiotech, Sweden). The probes were continuously perfused
with a Ringer solution containing 140 mM NaCl, 3.0 mM KCl,
1.2 mM CaCl2 and 1.0 mM MgCl2 and a GABA reuptake
inhibitor, NNC 711 (30 mM, Tocris Cookson Ltd, UK). The
animals were allowed to recover and were then kept in a standard
microdialysis bowl, with the fluid lines from the microdialysis
probes connected to the external equipment via a swiveled balance
arm. The perfusion rate was kept at 4.0 ml/min for one hour and
was then lowered to 1.5 ml/min. Baseline sampling commenced
after 2 hours of perfusion. Microdialysis samples were collected
every 30 minutes. After two baseline samples, stochastic vestibular
stimulation commenced. Microdialysis perfusion continued
throughout the 30 minute stimulation period, and for another
60 minutes, providing a total of 5 microdialysis samples from each
probe. The samples were split and analyzed for amino acid
content as described previously [33], and for amine content by
two-dimensional HPLC with electrochemical detection as de-
scribed by Lindgren et al. [34].
The 6-OHDA hemilesioned animals were subjected to a repeat
microdialysis experiment on the following day. The experiment
protocol was as described above, but instead of a 30 minutes
stimulation period, they were injected with L-DOPA and
benserazide (6 mg/kg and 12 mg/kg, respectively, i.p.) after the
second sampling period.
After the last microdialysis experiment animals were euthanized
and the brain was removed and fixed in paraformaldehyde. The
brains were sectioned and probe locations were determined with
reference to the Paxinos and Watson rat brain atlas [46]. Results
from probes with less than 50% of the active membrane in the
target nucleus were excluded. This reduced the final n of
investigated brain areas to 5 for PPN and VM and 10 for
striatum, 9 for SN respectively in intact animals. In 6-OHDA
lesioned animals, a total of 6 probes were included in the lesioned
SN, and 6 in the unlesioned. The positions of the active
membranes of all included probes are indicated in Fig. S5.
Stimulation protocol
Current was delivered through the bilateral electrodes using two
setups. Unlesioned animals were stimulated using two stimulus
isolators (NeuroLog NL800, Digitimer Ltd. Hertfordshire, UK)
connected to a biphasic pulse buffer unit (NeuroLog NL512) and a
stimulus pattern fed from a voltage source pulse generator or a
DAT recorder with a prerecorded stochastic stimulation (,30 Hz)
pattern. For lesioned animals a bipolar analogue stimulus isolator
(model 2200 A-M Systems, Sequim, Washington, U.S.A) was used,
and the stimulus pattern was fed from a low pass (,30 Hz) filtered
voltage source generator (BitScope 100 with BitGen coprocessor,
Metachip Pty. Ltd., Australia), which was programmed to
generate sinusoid or white noise patterned voltages.
Bipolar 1 Hz sinusoid stimulation pattern was used to determine
an appropriate maximum current. The amplitude was slowly
increased until a 1 Hz rocking of the animals head was clearly
visible. The lowest amplitude A that reproducibly produced head
Table 2. Maximum stimulation amplitudes (mA, mean6SEM)
in the different experiments.
Experiment Animals Mean±SEM (mA)
Rotarod 6-OHDA hemiles (n = 6) 0.3060.02
Sham hemiles (n = 5) 0.2760.03
Montoya staircase 6-OHDA hemiles (n = 5) 0.2360.05
Sham hemiles (n = 3) 0.2760.03
Microdialysis SN/ST, unlesioned (n = 9) 0.4860.02
PPN/VM, unlesioned (n = 5) 0.4160.03
Bilat SN, 6-OHDA hemiles (n = 7) 0.4760.08
Stimulation amplitudes were determined by subjecting the animals to a
sinusoid current that was increased until head rocking was just visible. During
stochastic stimulation the amplitude never exceeded 6 this amplitude. A
different current delivery system was used for the microdialysis experiments in
unlesioned animals. 6-OHDA 6-hydroxy-dopamine, PPN pedunculopontine
nucleus, ST striatum, SN substanta nigra, VM ventromedial thalamus.
doi:10.1371/journal.pone.0029308.t002
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rocking was used as maximum amplitude during the stochastic
vestibular stimulation period of the experiment.
The mean maximum stimulation amplitudes are given in
Table 2, and were typically between 0.2 and 0.6 mA. The
stochastic stimulation protocol consisted of a 30 minutes sequence
containing bipolar current with random amplitude between (2A)
and (+A) and random frequencies ,30 Hz. Examples of the
stimulation currents are given in Fig. S4.
Motor behavior – Rotarod
Animals were trained to run on a 6 cm (ø) accelerating rod.
Training and a set of prelesion baseline tests took place before any
surgical procedure, and animals were re-tested three weeks after
sham/6-OHDA lesion procedures. Each baseline test and
experimental test episode consisted of four 10 minute long
accelerations (5–40 rpm). The mean time on rod during each test
episode was determined as previously described [28]. Three to five
days after implantation of bilateral vestibular electrodes the
animals were baseline tested and after 30 minutes tested again
with or without vestibular stimulation.
Stimulation was started 30 minutes before the first of four rod
session, and continued throughout testing. This procedure was
repeated for two days in a counterbalanced order so that each
animal was tested one day with and one day without stimulation.
The same procedure was carried out over an additional two day
period, this time with either an L-DOPA and benserazide
intraperitoneal injection (6 mg/kg and 12 mg/kg respectively) or
a sham injection (NaCl 0,9%) given in a counterbalanced order
(Fig. 6). The change in performance invoked by the SVS or no
SVS condition was calculated with reference to the baseline
performance on the same day. 6-OHDA-lesioned animals with less
than 70% dopamine depletion (n = 5), as revealed by port-mortem
analysis, were excluded from the Rotarod data analysis.
Motor behavior - Montoya staircase test
Two weeks before the hemilesion procedure, rats were food
restrained to 90–95% of free feeding weight and trained to retrieve
sugar pellets (45 mg each; BioServ, Frenchtown, NJ, U.S.A.) in a
Montoya staircase apparatus (966630 cm, Campden Instruments
Ltd, Loughborough, UK). Training took place between 9am–1pm,
over a period of 5 days and consisted of 2615 min sessions in the
box with 1 h 45 min rest between sessions. The box was covered
with a dark cloth to maintain a dark and constant environment
throughout training and testing. Animals which after initial training
retrieved at least 9 pellets per side were included in the experiment.
Seven days after implantation of vestibular electrodes the rats were
food restrained and baseline tested. They were tested again over the
following two days with and without vestibular stimulation in a
counterbalanced order. Stimulation was applied for 30 minutes
immediately before the animal was transferred to the test box. 6-
OHDA lesioned animals with less than 70% dopamine depletion in
the post mortem analysis were excluded from analysis.
Statistical analysis
When appropriate, microdialysate concentrations were trans-
formed to percent of baseline to reduce the effects of recovery
variations. The treatment effect on neurotransmitter concentrations
was evaluated by repeated measure two-way ANOVA with treatment
and time as independent factors or with one sample t-tests with 100%
as the theoretical mean, as appropriate. Locomotion effects were
evaluated with paired t-tests comparing the change in time (s) on rod
observed during stimulation or no-stimulation conditions. On the
Montoya staircase, the overall number of sugar pellets consumed,
total number of pellets on each side as well as the ratio between
number of pellets eaten from impaired (contralesional) side and non-
impaired (ipsilesional) side after vestibular stimulation or after no
stimulation, were evaluated by paired t-tests. Data are given as
mean6SEM, and p#0.05 was considered statistically significant.
Supporting Information
Figure S1 Dopamine concentrations in dialysates from
the substantia nigra and striatum of normal animals.
Figure shows dopamine (DA) concentrations (percent of baseline,
mean6SEM) in dialysates from the SN and the contralateral
striatum of 9 un-lesioned animals subjected to stochastic vestibular
stimulation for 30 minutes (horizontal bar). Concentrations
remained stable throughout the stimulation period and the
following hour. For clarity, measurements from untreated control
animals (n = 6) are omitted from the figure. NNC 711 (30 mM)
was present in the perfusate throughout the experiment.
(TIF)
Figure 6. Schematic illustration of the experimental design for the Rotarod testing procedure. The black arrows represent training
episodes for each animal. Rod performance during stochastic vestibular stimulation (SVS) or no SVS was compared to the baseline measurement (BL,
4610 min before either condition) on the day of the experiment. The stimulated condition (30 min SVS in cage followed by 4610 min testing during
SVS) or non stimulated condition (30 min rest in cage followed by 4610 min testing during no SVS) was carried out in a counterbalanced order after
the BL measurements. L-DOPA testing was carried out in the beginning of the following week in counterbalanced order; BL testing followed by either
an L-DOPA or NaCl injection, rest in cage for 30 min followed by testing for 4610 min.
doi:10.1371/journal.pone.0029308.g006
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Figure S2 Amino acid concentrations in dialysates from
the substantia nigra of normal animals. Panel A shows the
relative concentrations (percent of baseline, mean6SEM) of
glutamate and glycine from the SN of un-lesioned animals
subjected to stochastic vestibular stimulation (SVS, horizontal
bar, n = 9) or no SVS (ctrl, n = 6) for 30 minutes. Over this time
there were no significant difference in relative concentrations
(Two-way repeated measure ANOVA for t = 90–t = 150 with SVS
treatment and time as main factors, Glutamate: Ftreat(1, 24) = 2.76,
p = 0.12, Ftime(2, 24) = 0.5, p = 0.61, Finteract(2,24) = 1.01, p = 0.38,
Glycine Ftreat(1, 26) = 1.36, p = 0.26, Ftime(2, 26) = 1.63, p = 0.21,
Finteract(2,26) = 1.34, p = 0.28). The higher mean values and large
variability in samples t = 120 and t = 150 coincided with increased
exploratory behavior in the cage. Taurine and glutamine levels
remained stable following SVS (Panel B, two-way repeated
measure ANOVA for t = 90–t = 150 with SVS treatment and
time as main factors, Taurine: Ftreat(1, 26) = 1.88, p = 0.19, Ftime(2,
26) = 1.63, p = 0.22, interact(2,26) = 0.44, p = 0.65, Glutamine
Ftreat(1, 26) = 1.71, p = 0.21, Ftime(2, 26) = 1.81, p = 0.18, Finter-
act(2,26) = 0.30, p = 0.75). NNC 711 (30 mM) was present in the
perfusate throughout the experiment.
(TIF)
Figure S3 Glutamate concentrations in dialysates from
the bilateral substantiae nigrae of 6-OHDA hemile-
sioned rats. Figure shows glutamate (GLU) concentrations
(percent of baseline, mean6SEM) in dialysates from the ipsi- and
contralesional SN before, during and after stochastic vestibular
stimulation (SVS, horizontal bar, 30 minutes) in panel A and in
response to L-DOPA treatment (6 mg/kg, i.p., arrow) in panel B.
NNC 711 (30 mM) was present in the perfusate throughout the
experiment.
(TIF)
Figure S4 Stochastic stimulation current patterns. Panel
A shows the stimulation current used in normal animals and panel
B the current used in hemilesioned rats. The time base is 200 ms
per division, and the upmost part of each panel shows the
frequency distribution.
(TIF)
Figure S5 Placement of microdialysis probes in intact
and hemilesioned animals. Unlesioned animals are shown
schematically in panel A (striatum and substantia nigra) and panel
B (ventromedial thalamus and the pedunculopontine nucleus).
Panel C shows the bilateral nigral locations in hemilesioned
animals. Solid lines indicate the estimated location of the active
dialysis membrane.
(TIF)
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